This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
epsis is a serious high mortality disease. As regards pathophysiology, it is a systemic inflammatory response to infection.
Its timely diagnosis strongly influences mortality. The identification of biomarkers is used for diagnosing, monitoring, and
prognosis in septic patients. The methods for their measurement cover a range of disciplines such as clinical biochemistry,
hematology, immunology, and clinical microbiology. The most frequently used sepsis markers in routine clinical diagnostics are
C-reactive protein and procalcitonin. The detection of selected cytokines, mediators, and surface markers in immunocompetent
cells gives us further chance for improvement of this diagnostics. The methods of calculating gene expression represent a
technology with a potential for the discovery of new biomarkers which would improve both diagnostics and therapy in the sense
of personalized medicine.
Miroslav Prucha is currently an Associate Professor of Clinical Immunology at Hospital na Homolce, Prague, Czech Republic. He got his Medicine
Doctor ́s degree (Ph.D.) at Masaryk ́s University, Brno, Czech Republic. He has more than 20 years of personal experience in different leadership
positions in the clinical immunology, clinical chemistry, and laboratory medicine field. He has been involved in a multitude of clinical trials in the field
of sepsis - diagnostics and therapy and asthma bronchiale and autoimmune diseases
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals